Skip to main content
Qualigen Therapeutics, Inc. logo

Qualigen Therapeutics, Inc. — Investor Relations & Filings

Ticker · QLGN ISIN · US74754R1032 US Professional, scientific and technical activities
Open in API
Filings indexed 618 across all filing types
Latest filing 2019-02-08 Director's Dealing
Country US United States of America
Listing US QLGN

About Qualigen Therapeutics, Inc.

https://qlgntx.com/

Qualigen Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company's efforts are directed toward creating therapeutics for both adult and pediatric patients, with a particular emphasis on rare cancers and areas of high unmet medical need. Its development approach combines internal capabilities with collaborations from major cancer research institutions. The company's investigational oncology pipeline includes programs such as QN-302, a Pan-RAS inhibitor platform, and QN-247.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2019-02-08 English
Delisting Announcement 2018
Delisting Announcement Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The key content is under Item 3.01, which is a Notice of Delisting or Failure to Satisfy a Continued Listing Rule. The document details that the company received a notice from Nasdaq about not meeting the minimum bid price requirement and outlines the compliance periods and potential consequences. This is a formal announcement regarding the potential delisting of the company's stock from Nasdaq. The document is not a full financial report, audit, or earnings release, but an official notice about listing status. Therefore, it fits the category of a Delisting Announcement (DLST). The document length is about 4983 characters, which is consistent with a detailed announcement rather than a brief notice or a full report. Hence, the classification is DLST with high confidence.
2018-12-28 English
Capital/Financing Update 2018
Capital/Financing Update Classification · 100% confidence The document is a prospectus filed pursuant to Rule 424(b)(3) related to the resale of shares by selling stockholders. It details the registration of shares, private placement summary, use of proceeds, risk factors, and other offering-related information. It is not a financial report, earnings release, or management discussion. It is a capital markets document related to financing and share registration for resale. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and content confirm it is a full prospectus, not just an announcement or a brief notice.
2018-12-03 English
Regulatory Filings 2018
Regulatory Filings
2018-12-03 English
Regulatory Filings 2018
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-3. It is a correspondence related to a securities registration process, specifically about the timing of the effectiveness of a registration statement. The document is short (1326 characters) and does not contain financial statements or detailed financial data. It is not the registration statement itself but a procedural request related to it. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and filings that do not fit other categories.
2018-11-29 English
Regulatory Filings 2018
Regulatory Filings Classification · 60% confidence The provided document text appears to be heavily encoded or encrypted, containing no readable or meaningful content related to financial reporting, regulatory announcements, or corporate filings. There are no discernible keywords, regulatory body mentions, form names, fiscal period dates, or document titles that would allow classification into any specific filing category. Given the lack of interpretable content and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS). The confidence is moderate due to the inability to extract meaningful information but the clear indication that this is not a standard report or announcement.
2018-11-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.